Seasonal Influenza Vaccines Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-2233 | Report Format : | Status : Upcoming |

Abstract

Seasonal Influenza Vaccines Therapeutics Market: Overview

Influenza vaccine is also called as the flu shot. It is used to protect against the infection of the influenza virus. An influenza vaccine has a mixture of 3 viruses type which includes influenza type B virus strain, influenza type A having the H3N2 virus strain, and influenza type A having the H1N1 virus strain. Influenza is a respiratory illness that is contagious which may lead to mild or severe disease. It may lead to death of the patient. The classification of the influenza virus is done on the basis of H1N1 (influenza A) virus, H3N2 (influenza A) virus, and one or two influenza B viruses. The symptoms shown by the patients include cough, running nose, headache chills, diarrhea, sore throat, body aches, fatigue, and vomiting.

Seasonal Influenza Vaccines Therapeutics Market: Facts

The Australian Influenza Vaccine Committee (AIVC) has assessed and evaluated the data that is related to the strains of influenza that were present in the regions of Australia and the Southern Hemisphere. On the basis of this review, the AIVC recommended the TGA to adopt the September 2016 World Health Organization (WHO) proposals for the strains to be covered by the 2017 seasonal influenza vaccines.

Seasonal Influenza Vaccines Therapeutics Market: Segmentation

The global market for the seasonal influenza vaccines therapeutics is fragmented into its end-users and the treatment type. On the basis of the end-user, the global market is segregated into hospitals, clinics, and medicals. On the basis of the patient type, the market is divided into adolescence, elderly, pediatrics, and adults. On the basis of the treatment type, the global market is categorized into antiviral therapies and vaccines.

Seasonal Influenza Vaccines Therapeutics Market: Growth Factors

The major factors that are driving the seasonal influenza vaccines therapeutics market are wider coverage of the vaccination, growing disease awareness about influenza, and the rise in the support of the government for the immunization purposes against seasonal influenza. There is a huge pipeline of products that are made by the major market players thus making the portfolio of the product strong. The key factors that are restraining the growth of the market are limited production capacity, strict regulations imposed, variable demand, and high level of required investment.

Seasonal Influenza Vaccines Therapeutics Market: Regional Analysis

The regions where the seasonal influenza vaccines therapeutics market is expanded includes New Zealand, Taiwan, Hong Kong, India, Japan, Australia, China, Philippines, Singapore, and Malaysia. In the recent years, the market witnessed a healthy growth in the countries such as France, Italy, the U.K., the U.S., Germany, Spain, and Japan. In Asia Pacific region, Philippines have the most attractive market for seasonal influenza vaccines.

Seasonal Influenza Vaccines Therapeutics Market: Competitive Players

The key market players that are involved in the seasonal influenza vaccines therapeutics market include Novartis, MedImmune, Solvay, Hualun Biologicals, Seqirus, MedImmune, GlaxoSmithKline, CSL, Sanofi-Pasteur, Sinovac Biotech, ID Biomedical Corp. of Quebec, and Protein Sciences.

Seasonal Influenza Vaccines Therapeutics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Peptide and Anticoagulant Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3130 | Report Format:

Global Peptide and Anticoagulant Drugs Market: Overview Peptides anticoagulant drugs are likely to have a wide range of applications in treating several diseases for example osteoporosis, cancer, cardiovascular, diabetes, and coagulation disorders. Peptides are basically molecules that are univ...Read More

Crohn’s Disease Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3033 | Report Format:

Global Crohns Disease Market: Overview An inflammatory disease of bowel affecting any part of the Gastro-Intestinal Tract (GI Tract) is termed as Crohns disease. It is classified into a segment of chronic disease. Crohns disease is considered to impact nearly every part of an individuals life, a...Read More

Anti-Neoplastic Agents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3024 | Report Format:

Global Anti-Neoplastic Agents Market: Overview Anti-neoplastic agents are primarily used as a first-line treatment for cancer therapy as well as in combination with radiation or surgical therapy. A lot of anti-neoplastic agents are accessible commercially for the therapy of various kinds of canc...Read More

Kidney Fibrosis Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-2989 | Report Format:

Global Kidney Fibrosis Treatment Market: Overview Fibrosis is the growth of extreme connective tissue owing to some injury or some disease. Disease in the kidney can cause kidney fibrosis. In this state, the kidneys fail to work properly which gradually leads to severe conditions. Kidney transpl...Read More

Oncology Based In-vivo CRO Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2982 | Report Format:

Global Oncology Based In-vivo CRO Market: Overview CRO basically stands for contract research organization which presents research services to a pharmaceutical, biotechnology, and medical devices key players on the basis of the contract. CRO offers services such as clinical research, biologic as...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.